| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 09/24/1998 | WO1998041525A1 Pyrrolo[2,3d]pyrimidines and their use as tyrosine kinase inhibitors |
| 09/24/1998 | WO1998041519A1 Novel cannabinoid receptor agonists |
| 09/24/1998 | WO1998041512A1 Substituted 2-anilinopyrimidines useful as protein kinase inhibitors |
| 09/24/1998 | WO1998041232A2 Compositions for modulating responsiveness to corticosteroids |
| 09/24/1998 | WO1998041228A1 Transmucosal induction of tolerance to parenterally administered non-autologous polypeptides |
| 09/24/1998 | WO1998041225A1 Pharmaceutical compositions |
| 09/24/1998 | DE19711800A1 Verlängerung der Expression von transgenen Proteinen durch immunmodulierende Behandlung Extension of the expression of transgenic proteins by modifying treatments |
| 09/24/1998 | CA2644454A1 Death domain containing receptor 5 |
| 09/24/1998 | CA2284109A1 Secreted proteins and polynucleotides encoding them |
| 09/24/1998 | CA2284062A1 Transmucosal induction of tolerance to parenterally administered non-autologous polypeptides |
| 09/24/1998 | CA2283961A1 Pyrrolo[2,3d]pyrimidines and their use as tyrosine kinase inhibitors |
| 09/24/1998 | CA2283901A1 Pharmaceutical compositions |
| 09/24/1998 | CA2283896A1 Novel pyrimidine derivative |
| 09/24/1998 | CA2283797A1 Novel cannabinoid receptor agonists |
| 09/24/1998 | CA2282845A1 Methods and compositions for modulating responsiveness to corticosteroids |
| 09/23/1998 | EP0866128A2 Recombinant ricin toxin |
| 09/23/1998 | EP0866126A1 CDNA clone HNFDY20 that encodes a novel human 7-transmembrane receptor |
| 09/23/1998 | EP0865491A1 Compounds having lectin properties and biological uses thereof |
| 09/23/1998 | EP0865431A2 Compounds |
| 09/23/1998 | EP0865428A1 Vitamin d analogues |
| 09/23/1998 | EP0865419A1 Indane dimer compounds and their pharmaceutical use |
| 09/23/1998 | EP0865297A1 Vaccine compositions for intranasal administration comprising chitosan and use thereof |
| 09/23/1998 | EP0865293A1 Blockade of t lymphocyte down-regulation associated with ctla-4 signaling |
| 09/23/1998 | EP0865275A2 Graft survival prolongation with porphyrins |
| 09/23/1998 | EP0749481B1 Humanized monoclonal antibodies against human interleukin-4 |
| 09/23/1998 | EP0711280B1 Perhydroisoindole derivatives as p substance antagonists |
| 09/23/1998 | EP0604418B1 Isolated viral protein cytokine antagonists |
| 09/23/1998 | EP0539421B1 Novel oxazolyl derivatives |
| 09/23/1998 | CN1194005A Method for producing influenza hemagglutinin multivalent vaccines |
| 09/23/1998 | CN1194000A Methods for enhancement of protective immune responses |
| 09/23/1998 | CN1193980A G-protein receptor HTNAD 29 |
| 09/23/1998 | CN1193979A Macrolides |
| 09/23/1998 | CN1193978A Peptidyl compounds and their therapeutic use as inhibitors of metalloproteases |
| 09/23/1998 | CN1193910A Use of alicyclic diamines as immunomodulators |
| 09/23/1998 | CN1193907A Preparation and methods for the treatment of T cell mediated diseases |
| 09/22/1998 | US5811562 Pharmceutical compositions for the treatment of osteoporosis, wound healing, transplant rejection, rheumatoid arthritis |
| 09/22/1998 | US5811553 Quinoline derivatives(2) |
| 09/22/1998 | US5811549 Process of preparing imidazole compounds |
| 09/22/1998 | US5811548 Tri-and tetracyclic compounds |
| 09/22/1998 | US5811464 Use of 2-methylamino-2-phenylcyclohexanone for the treatment of bacterial, fungal, virus or protozoan infections as well as for immunomodulation |
| 09/22/1998 | US5811455 Compounds useful for treating allergic or inflammatory diseases |
| 09/22/1998 | US5811451 Antiinflammatory agents; infections; osteoporosis; autoimmune diseases; human and veterinary medicine; cattle, dogs, horses; gastrointestinal and respiratory dsystem disorders; glandular disorders |
| 09/22/1998 | US5811431 Treating or preventing pain, inflammation, migraine, emesis, postherpetic neuralgia |
| 09/22/1998 | US5811410 Nonsteroidal antiinflammatory drugs |
| 09/22/1998 | US5811405 Pharmaceuticals, diagnostic agents |
| 09/22/1998 | US5811400 Analgesics, immunosuppressive agents |
| 09/22/1998 | US5811389 Inhibiting platelet aggregation; blood disorders |
| 09/22/1998 | US5811297 Immortalized hematopoietic cell lines, cell system thereof with stromal cells, in vitro, ex vivo and in vivo uses, & in vitro generation of dendritic cells and macrophages |
| 09/22/1998 | US5811106 Polypeptides produced by human malaria parasites |
| 09/22/1998 | US5811097 Decreasing growth of tumor cells by administering blocking agent which binds to extracellular domain of cytotoxic t-lymphocyte-associated molecule and inhibits signaling |
| 09/22/1998 | CA2115279C Pharmaceutical products with a content of dexpanthenol for topical applications |
| 09/22/1998 | CA2093797C Substituted imidazobenzazepines and imidazopyridoazepines |
| 09/21/1998 | CA2232787A1 Antiallergic agent having an anti-oxidant action |
| 09/19/1998 | CA2224128A1 Cdna clone hnfdy20 that encodes a novel human 7-transmembrane receptor |
| 09/17/1998 | WO1998040501A1 Vectors having enhanced expression, and methods of making and uses thereof |
| 09/17/1998 | WO1998040500A1 Vectors having enhanced expression and methods of making and uses thereof |
| 09/17/1998 | WO1998040483A2 28 human secreted proteins |
| 09/17/1998 | WO1998040381A1 Inhibitors of impdh enzyme |
| 09/17/1998 | WO1998040380A1 Indolyl-pyrrolydenemethylpyrrole derivatives and process for their preparation |
| 09/17/1998 | WO1998040094A1 Hydrophilic binary systems for the administration of cyclosporine |
| 09/17/1998 | WO1998040065A1 Hydroxy and ether-containing oxyalkylene esters and uses thereof |
| 09/17/1998 | WO1998040051A1 Lipophilic binary systems for the administration of lipophilic compounds |
| 09/17/1998 | WO1998039970A1 Quinoline leukotriene antagonists |
| 09/17/1998 | WO1998031343A3 Aqueous suspension for nasal administration of loteprednol |
| 09/17/1998 | WO1998024905A3 Secreted proteins and polynucleotides encoding them |
| 09/17/1998 | DE19708713A1 Verwendung von anti-CD44 Antikörpern enthaltenden Präparationen zur Behandlung bestimmter Tumore und zur Unterdrückung von Immunreaktionen Using anti-CD44 antibodies containing preparations for the treatment of certain tumors and for the suppression of immune responses |
| 09/17/1998 | CA2283780A1 Lipophilic binary systems for the administration of lipophilic compounds |
| 09/17/1998 | CA2283678A1 28 human secreted proteins |
| 09/17/1998 | CA2283173A1 Hydroxy and ether-containing oxyalkylene esters and uses thereof |
| 09/17/1998 | CA2282398A1 Inhibitors of impdh enzyme |
| 09/17/1998 | CA2253588A1 Indolyl-pyrrolydenemethylpyrrole derivatives and process for their preparation |
| 09/16/1998 | EP0864653A1 Process for production of 4-(4-(4-(hydroxydiphenyl)-1-piperidinyl)-1-hydroxybutyl)-alpha, alpha-dimethylphenyl acetic acid and phosphorylated derivatives |
| 09/16/1998 | EP0864323A1 Pharmaceutical preparation for oral application containing a histamine-immunoglobulin complex |
| 09/16/1998 | EP0863991A1 Antigenic preparations |
| 09/16/1998 | EP0863915A1 ACYLATED ENOL DERIVATIVES OF $g(a)-KETOESTERS AND $g(a)-KETOAMIDES |
| 09/16/1998 | EP0863905A1 Novel imidazole lipoxygenase inhibitors |
| 09/16/1998 | EP0863883A1 Alpha-(1,3-dicarbonylenol ether) methyl ketones as cysteine protease inhibitors |
| 09/16/1998 | EP0863873A1 Indole carbamates as leukotriene antagonists |
| 09/16/1998 | EP0863870A1 Sulfur containing di-tert-butylphenol compounds useful as anti-inflammatory agents |
| 09/16/1998 | EP0863765A1 Pharmaceutical compositions of macrolides or cyclosporine with a polyethoxylated saturated hydroxy-fatty acid |
| 09/16/1998 | EP0863757A1 2-substituted aryl pyrroles, compositions containing such compounds and methods of use |
| 09/16/1998 | EP0863704A1 Stimulation of cell-mediated immune responses by targeted particulate genetic immunization |
| 09/16/1998 | EP0833629A4 Aryl acrylic acid derivatives useful as protein tyrosine phosphatase inhibitors |
| 09/16/1998 | EP0733047B1 Substituted oxazolidines with stimulating effect of beta-adrenergig receptor |
| 09/16/1998 | EP0706574B1 Methods for peptide synthesis and purification |
| 09/16/1998 | EP0699442B1 Use of a strain of the fungus fusarium as a producer of substances and a preparation based on said substances with adaptogenic and immunomodulating properties |
| 09/16/1998 | EP0661930B1 Viscous liquid xylitol compositions and method for preparing same |
| 09/16/1998 | EP0520032B1 Use of spiperone as an immunosuppressant and anti-inflammatory agent |
| 09/16/1998 | CN1193353A Allergen-XCD32 fusion proteins |
| 09/16/1998 | CN1193350A Antigen non-specific glycosylation inhibiting factor derivatives |
| 09/16/1998 | CN1193325A Cell adhension inhibitors |
| 09/16/1998 | CN1193324A Acellular pertussis vaccines and method of preparation thereof |
| 09/16/1998 | CN1193022A Heterocyclic compound used as leucocyte adherence inhibitor and VLA-4 antagonist |
| 09/16/1998 | CN1192929A Oral medicinal preparation |
| 09/15/1998 | US5808029 Genetic engineering |
| 09/15/1998 | US5808025 Polypeptide |
| 09/15/1998 | US5807992 Vaccines; medical diagnosis |
| 09/15/1998 | US5807988 Isolation, characterization, and use of the human and subunit of the high affinity receptor for immunoglobulin E |
| 09/15/1998 | US5807951 Pharmaceutical composition regulating function of a living body |
| 09/15/1998 | US5807886 Treatment of neurodegenerative disorders, migraine, drug addiction |